West Pharmaceutical Services Inc (WST)

Surgical & Medical Instruments & Apparatus

Latest Price

$370.76

TTM P/E

48.22

Normalized P/E

51.03

Div Yield

0.23%

Book Value

42.33

P/B Ratio

8.76

Valuation metrics

EPS: $6.79

Book value / share: $44.11

Formula: √(22.5 × EPS × BVPS)

Graham Number

$82.09

78% downside

Norm. op. income: $585M (median of 7yr)

Tax rate: 18%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$74.73

80% downside

Base FCF: $415M (median of recent 5yr)

Growth: 17%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$253.49

32% downside

EPS: $6.79

Target P/E: 50×

Formula: EPS × P/E

P/E Fair Value

$339.50

8% downside

99.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	6.65M	$2.39B	9.45%	-184.9K	2026-06-30
Vanguard Capital Management LLC	4.61M	$1.66B	6.55%	-70.2K	2026-06-30
Vanguard Portfolio Management LLC	4.02M	$1.44B	5.70%	-78.2K	2026-06-30
FMR LLC	3.57M	$1.28B	5.08%	+2.33M	2026-06-30
State Street Corp	3.35M	$1.20B	4.76%	+54.9K	2026-06-30
Artisan Partners Limited Partnership	2.41M	$865.0M	3.43%	-246.1K	2026-06-30
Bank of New York Mellon Corp	2.04M	$733.0M	2.90%	-422.0K	2026-06-30
Generation Investment Management LLP	2.03M	$728.0M	2.88%	-215.7K	2026-06-30
Geode Capital Management, LLC	1.90M	$680.0M	2.70%	-9.2K	2026-06-30
T. Rowe Price Investment Management, Inc.	1.81M	$648.0M	2.56%	-535.4K	2026-06-30